Table 1.
Descriptive Statistics and Bivariate Relationships Between the Number of Types of Intimate Partner Violence Women Experienced During Their Lifetimes and Other Study Variables (n = 243)
| # of Types of IPV |
|||||
|---|---|---|---|---|---|
| Total sample (n = 243) | None (n = 92) | 1 (n = 85) | 2 or 3 (n = 66) | p Value | |
| Variable | |||||
| Age (mean, SD) | 25.3 (5.8) | 24.3 (5.8) | 24.7 (5.4) | 27.3 (5.9) | 0.004 |
| Psychological distress (%) | 0.112 | ||||
| Yes | 16.5 | 15.2 | 11.8 | 24.2 | |
| No | 83.5 | 84.8 | 88.2 | 75.8 | |
| Race/ethnicity (%) | 0.084 | ||||
| White | 18.1 | 12.0 | 21.2 | 22.7 | |
| Hispanic | 28.8 | 30.4 | 28.2 | 27.3 | |
| Black or African American | 33.3 | 32.0 | 40.0 | 25.8 | |
| Other | 19.8 | 25.0 | 10.6 | 24.2 | |
| Education (%) | 0.742 | ||||
| Less than high school | 14.8 | 13.0 | 14.1 | 18.2 | |
| High school graduate | 25.5 | 31.5 | 23.5 | 19.7 | |
| Some college | 47.7 | 44.6 | 49.4 | 50.0 | |
| College graduate or more | 11.9 | 10.9 | 12.9 | 12.1 | |
| Marital status (%) | 0.187 | ||||
| Married | 7.0 | 5.4 | 10.6 | 4.6 | |
| Cohabiting | 27.6 | 23.9 | 31.8 | 27.3 | |
| Divorced or separated | 9.1 | 8.7 | 4.7 | 15.2 | |
| Never married | 56.4 | 62.0 | 52.9 | 53.0 | |
| Number of prior abortions (%) | 0.116 | ||||
| None | 39.9 | 46.7 | 42.4 | 27.3 | |
| 1 | 24.3 | 21.7 | 28.2 | 22.7 | |
| 2 | 18.9 | 18.5 | 12.9 | 27.3 | |
| 3 | 7.8 | 7.6 | 8.2 | 7.6 | |
| 4 or more | 9.1 | 5.4 | 8.2 | 15.2 | |
| Number of children (%) | 0.521 | ||||
| None | 40.7 | 46.7 | 40.0 | 33.3 | |
| 1 | 28.4 | 28.3 | 31.8 | 24.2 | |
| 2 | 18.1 | 15.2 | 16.5 | 24.2 | |
| 3 | 6.2 | 4.3 | 4.7 | 10.6 | |
| 4 | 3.7 | 3.3 | 4.7 | 3.0 | |
| 5 or more | 2.9 | 2.2 | 2.4 | 4.6 | |
| Very important to avoid pregnancy (%) | 0.178 | ||||
| Yes | 70.4 | 34.8 | 30.6 | 21.2 | |
| No | 29.6 | 65.2 | 69.4 | 78.8 | |
| Abortion trimester (%) | 0.836 | ||||
| First | 39.9 | 40.2 | 37.7 | 42.4 | |
| Second | 60.1 | 59.8 | 62.4 | 57.6 | |
| Main method plan to use in next 6 months (assessed before contraceptive counseling) (%) | 0.549b | ||||
| Low effectiveness | 14.8 | 15.2 | 15.3 | 13.6 | |
| Condoms | 10.7 | 12.0 | 9.4 | 10.6 | |
| No method | 4.1 | 3.3 | 5.9 | 3.1 | |
| Moderate effectiveness | 56.4 | 59.8 | 52.9 | 56.1 | |
| Oral contraceptive pill | 24.3 | 27.2 | 16.5 | 30.3 | |
| Transdermal patch | 7.4 | 8.7 | 5.9 | 7.6 | |
| Vaginal ring | 4.5 | 3.3 | 5.9 | 4.6 | |
| Injectable (DMPA) shot | 20.2 | 20.7 | 24.7 | 13.6 | |
| High effectiveness | 28.8 | 25.0 | 31.8 | 30.3 | |
| Tubal ligationa | 3.3 | 2.2 | 3.5 | 4.6 | |
| Contraceptive implant | 3.7 | 3.3 | 1.2 | 7.6 | |
| Intrauterine device | 21.8 | 19.6 | 27.1 | 18.2 | |
| Method selected (assessed after contraceptive counseling and abortion) (%) | 0.200b | ||||
| Low effectiveness | 15.2 | 19.6 | 17.6 | 6.1 | |
| Condoms | 9.9 | 15.2 | 10.6 | 1.5 | |
| Emergency contraception | 0.4 | 1.1 | 0.0 | 0.0 | |
| No method | 4.9 | 3.3 | 7.1 | 4.6 | |
| Moderate effectiveness | 42.0 | 40.2 | 42.4 | 43.9 | |
| Oral contraceptive pill | 20.6 | 23.9 | 14.1 | 24.2 | |
| Transdermal patch | 4.1 | 4.3 | 3.5 | 4.6 | |
| Vaginal ring | 4.1 | 2.2 | 4.7 | 6.1 | |
| Injectable (DMPA) shot | 13.2 | 9.8 | 20.0 | 9.1 | |
| High effectiveness | 42.8 | 40.2 | 40.0 | 50.0 | |
| Contraceptive implant | 4.1 | 4.3 | 3.5 | 4.5 | |
| Intrauterine device | 38.7 | 35.9 | 36.5 | 45.5 | |
Chi-square tests were used for categorical variables and one-way ANOVA was performed for age. Some totals do not sum to 100 due to rounding. Significance level for categories of low, moderate, and high effectiveness levels (bold numbers) for contraceptive method women were planning to use and the contraceptive method they selected were 0.874 and 0.175, respectively.
Tubal ligation could be the most effective method they were thinking to use post-abortion before contraceptive counseling; however, tubal ligation was not a method the woman could take home.
Relationship between number of types of lifetime IPV experienced and contraceptive method effectiveness level.
SD, standard deviation; ANOVA, analysis of variance; IPV, intimate partner violence; DMPA, depot medroxyprogesterone acetate.